Related Experiment Video
Updated: Sep 4, 2025

MicroRNA-based Regulation of Picornavirus Tropism
Published on: February 6, 2017
Pathogenic Role of MicroRNA Dysregulation in Podocytopathies
Feng Liu1, Jiefang Chen2, Changqing Luo1
1Department of Nephrology, Union Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan, China.
Abstract:
MicroRNAs (miRNAs) participate in the regulation of various important biological processes by regulating the expression of various genes at the post-transcriptional level. Podocytopathies are a series of renal diseases in which direct or indirect damage of podocytes results in proteinuria or nephrotic syndrome. Despite decades of research, the exact pathogenesis of podocytopathies remains incompletely understood and effective therapies are still lacking. An increasing body of evidence has revealed a critical role of miRNAs dysregulation in the onset and progression of podocytopathies. Moreover, several lines of research aimed at improving common podocytopathies diagnostic tools and avoiding invasive kidney biopsies have also identified circulating and urine miRNAs as possible diagnostic and prognostic biomarkers for podocytopathies. The present review mainly aims to provide an updated overview of the recent achievements in research on the potential applicability of miRNAs involved in renal disorders related to podocyte dysfunction by laying particular emphasis on focal segmental glomerulosclerosis (FSGS), minimal change disease (MCD), membranous nephropathy (MN), diabetic kidney disease (DKD) and IgA nephropathy (IgAN). Further investigation into these dysregulated miRNAs will not only generate novel insights into the mechanisms of podocytopathies, but also might yield novel strategies for the diagnosis and therapy of this disease.
Insights
MicroRNAs (miRNAs) are key regulators in kidney podocyte diseases. Dysregulated miRNAs offer potential as diagnostic biomarkers and therapeutic targets for podocytopathies like FSGS, MCD, MN, DKD, and IgAN.
Area of Science:
- Molecular Biology
- Nephrology
- Biochemistry
Background:
- MicroRNAs (miRNAs) regulate gene expression post-transcriptionally, impacting vital biological processes.
- Podocytopathies, characterized by podocyte damage, lead to proteinuria and nephrotic syndrome, with unclear pathogenesis and limited therapies.
- miRNA dysregulation is increasingly implicated in the development and progression of podocytopathies.
Purpose of the Study:
- To review recent advancements in understanding the role of miRNAs in podocyte dysfunction-related renal disorders.
- To highlight the potential of miRNAs as diagnostic and prognostic biomarkers for podocytopathies.
- To explore novel therapeutic strategies targeting miRNAs in kidney diseases.
Main Methods:
- Literature review of recent research on miRNAs in podocytopathies.
- Analysis of studies focusing on miRNA dysregulation in specific renal diseases.
- Examination of research on circulating and urinary miRNAs as biomarkers.
Main Results:
- miRNA dysregulation plays a critical role in the pathogenesis of podocytopathies.
- Circulating and urinary miRNAs show promise as non-invasive diagnostic and prognostic biomarkers.
- Specific miRNAs are implicated in focal segmental glomerulosclerosis (FSGS), minimal change disease (MCD), membranous nephropathy (MN), diabetic kidney disease (DKD), and IgA nephropathy (IgAN).
Conclusions:
- Dysregulated miRNAs are central to podocytopathy mechanisms.
- Further research into these miRNAs can uncover novel diagnostic and therapeutic approaches for kidney diseases.
- miRNAs represent a promising avenue for improving the management of podocytopathies.
Related Concept Videos
MicroRNAs
Fungal Phylum Microsporidia
Cystic Fibrosis: Pathogenesis
CF is primarily caused by a genetic mutation in a chromosome 7 gene coding for the cystic fibrosis transmembrane conductance regulator (CFTR) protein. The most common gene mutation leading to CF is the ΔF508 mutation,...
Abnormal Proliferation
Cancer Cell Migration through Invadopodia
Receptor Downregulation in MVBs
The EGFR can initiate signaling pathways that lead to cell proliferation, migration, and differentiation. Overexpression of EGFR stimulates cells to proliferate. Excessive EGFR...

